Skip to main content

In an era when workers are returning to offices, here’s how Dropbox is making remote jobs work

NEW YORK (AP) — Many companies ended remote work arrangements that began during the coronavirus pandemic despite resistance from employees who grew accustomed to working from home.

Dropbox has no plans to return its workers to offices. After adopting a “virtual-first” staffing model in 2020, the San Francisco technology company met all of its financial goals and remains committed to making remote work the norm for the vast majority of its employees, according to Chief People Officer Melanie Rosenwasser.

“The pandemic tested our assumption that we have to be in person in order to be productive,” she said.

Allowing employees to work from anywhere helps Dropbox retain talent, said Rosenwasser, who leads the cloud storage provider’s human resources teams. Over time, the company refined scheduling practices, meeting protocols and employee well-being programs to better meet the needs of its “distributed” workforce, she said.

“It’s especially important to us to maintain this posture as so many other companies across many, many industries are mandating return to office,” Rosenwasser said.

In an interview with The Associated Press, Rosenwasser reflected on the ways Dropbox thrives with remote workers and creates in-person events to build community. Her responses were edited for brevity and clarity.

AP: Why did Dropbox choose a virtual-first model?

ROSENWASSER: We are explicitly not hybrid. We think this is the worst of all worlds, where employees suffer through long commutes only to sit on Zoom because most of our colleagues are distributed. We really believed in this creation of an even playing field. The rules of that are, largely, individual work is done remotely by everyone, but we still come together in person at least quarterly for strategy setting, connection, team building and bonding.

The model is fundamentally built on this notion that flexibility and agency are these new currencies of modern work. We see benefits in recruiting, engagement, employee retention and cost savings.

AP: How does it work?

ROSENWASSER: We put a lot of intention behind how we would bring this to life. We are asynchronous by default, which means we do a lot of our communication and even decision-making in writing. We have a structure called core collaboration hours. These are four-hour blocks for meetings that overlap by time zone. The rest of the time is yours for deep work, answering emails, continuing individual work on projects.

We’re also really obsessed with meeting hygiene. When we do come together and meet, we want to be really intentional on the rules of engagement. We focus on something that we call the three D’s: discuss, debate or decide. If none of those things are on the table, then a meeting is not required.

AP: Outside core collaboration hours, can people set their own schedules?

ROSENWASSER: The core collaboration hours are great because everyone knows that this is when you’re meeting with colleagues. Outside of that, you design your workday according to your preferences. Some people log off earlier in the afternoon because they have things they need to do with their children, but they log on later on at night because that is the way that they want to work. We allow for that, and every team contracts on these things so everyone knows what each other’s working schedule is and accommodates.

AP: What challenges do you face with the virtual-first model?

ROSENWASSER: The first is around burnout and the importance of setting boundaries. When you’re working from home, your personal and professional life blur, and that’s why we wanted to intentionally put into place non-linear workdays which are very much based on personal preferences.

When you’re working remotely, you’re very sedentary. We piloted a program called “Meet & Move.” We took a set of employees, and all of the meetings they took for the week were on the phone and they were moving. They could take a walk outside or move throughout their house, but they were not sitting in front of a camera.

We have this companywide meeting-effectiveness initiative. It’s not actually the number of meetings that’s the problem. It’s the fragmentation of these meetings. For example, you have a couple of meetings in the morning, then you’ve got a 15-minute break, then you’ve got another hour-and-a-half, and you’ve got a 30-minute break. When this happens, you can’t really do anything meaningful in those 15- or 30-minute breaks between meetings.

On the HR team, we eliminated all legacy meetings that no longer served us. We built our meetings where we would batch them. Mondays and Wednesdays are for one-on-ones, Tuesdays are for team meetings, Fridays are for interviews. We all tried to adhere to the same schedule. We had more efficiently restructured meetings, more focused time. Now we’re thinking about rolling this out more broadly to the company.

AP: How do you build community?

ROSENWASSER: There’s a relationship tax when you work remotely. Because you’re not in person every day, you don’t have these natural moments of connection. Quarterly off-sites are one of the best ways to build teamwork and strengthen sense of belonging. We have an off-site team that is dedicated to helping leaders put together an agenda, guest speakers, location and hotels.

We had to be really intentional about onboarding because it takes place remotely. Everyone gets an onboarding buddy, which is somebody likely on their team. They show them the ropes, meet with them every day, and eventually it turns into weekly meetings. They also get a mentor, and this could be someone that sits within their team or outside of their team.

People who live in and around the same city come together every week, every other week, for various events. It could be a volunteer event. When we have executives in town in certain cities, we’ll do fireside chats with them and invite all the folks (who work in that area) to come. Everything is basically subsidized, and they’re not mandatory.

AP: What did Dropbox leaders need to unlearn to make this work?

ROSENWASSER: There is a perception that when you’re in the office and you can actually physically see the people on your team, you can just assume they’re doing what they’re supposed to be doing. But I think we all know from working in offices that’s not necessarily true. There are tons of distractions. You’ve got gyms and on-site yoga and all kinds of things that are distracting, let alone the number of people that can walk by your desk to start a conversation when you’re midthought.

Today, every single person at Dropbox can see what every team’s responsible for, every item on the roadmap, when things are going to be done, how those things are going to be done. We’re extremely transparent about our goals and what teams are doing.

We don’t have to micromanage their presence because we set these goals and either they hit them or they don’t hit them, so this has become a really important aspect of our operating model, is assertive goal-setting and clarity.

All of our meetings start with a written document. People will, for the first five or 10 minutes of the meeting, read it and then they come on camera, and then we discuss it. It’s been really great for clarity of thought because clear writing is effectively clear thinking, so it forces you to put your thoughts and your proposal into a format that can be digested.

___

Share your stories and questions about workplace wellness at cbussewitz@ap.org. Follow AP’s Be Well coverage, focusing on wellness, fitness, diet and mental health at https://apnews.com/hub/be-well

When you have advanced prostate cancer: What living with the disease looks like

(CNN) — “How long do I have to live ?”When I tell a patient he has prostate cancer, this is usually what he asks me first.With early-stage or low-grade prostate cancer, I can offer strong reassurance: Your life expectancy is good — expect a five-year relative survival rate of greater than 99% with treatment. Simply put, most men will not die from low-grade prostate cancer.However, once the cancer has spread outside the prostate to the bones and other organs the answer becomes more difficult. Treatment has changed dramatically over the past decade for advanced prostate cancer. New drugs, better imaging and the earlier use of combined therapies are helping men live longer.In a video released July 15, former President Joe Biden gave an update on his prostate cancer, saying he was receiving treatments that have been going well. In May 2025, Biden officially announced that he had an aggressive form of prostate cancer that had spread to his bones. Since then, based on official updates, he has continued hormone therapy, completed a course of radiation and maintained a public presence.His diagnosis brought renewed attention to prostate cancer screening and treatment. Now, more than a year later, his cancer journey offers an opportunity to examine what has changed in the treatment of advanced prostate cancer — and the hope these offer men living with the disease.I recently saw a patient who was diagnosed three years ago with cancer that had already spread to multiple areas in his bones. Since then, he has taken cruises, traveled with his family and spent weekends babysitting his grandchildren.He gets tired and cannot garden the way he once did. But he is still alive and considers every day a blessing. His experience, and what we see with Biden, shows what living with metastatic prostate cancer can look like today.Understanding survival ratesIf they haven’t asked their doctor already, many patients go online and find five-year survival rates, but every number they may find online comes with a huge asterisk.The American Cancer Society reports five-year relative survival of greater than 99% when prostate cancer is found in or near the prostate. The figure drops to 38% when it has reached distant parts of the body.But that number is based on large groups of men treated years ago. It does not fully reflect the impact of newer treatments — or account for an individual man’s age, overall health and response to therapy.Survival statistics describe groups of patients but do not predict what will happen to one person. That is why the 38% figure cannot tell us how long Biden — or any individual patient — will live. These patients’ outlook depends on details of their cancer and how they are responding to treatments.It’s treated more aggressively nowA man diagnosed with metastatic prostate cancer a decade ago and a man diagnosed today would not receive the same treatment. The thinking now is to use our best treatments early instead of holding back.For years, doctors began with hormone therapy — usually injections that lower testosterone — and saved other treatments until the cancer stopped responding.Today, those injections are often combined from the start with a newer hormone-blocking drug and/or chemotherapy. These combinations have helped men live longer and are one of the biggest shifts of the past decade.What Biden’s diagnosis told usThere are three details about Biden’s cancer that help doctors like me understand how aggressive it is and how to manage it effectively. Official statements highlighted that his cancer had a Gleason score of 9. The cancer had spread to his bones, and it was labeled as hormone-sensitive.The Gleason score is assigned after a pathologist examines biopsy samples. Scores typically range from 6 to 10, with higher numbers indicating more aggressive cancer. A score of 9 falls into the most aggressive category. However, the score alone cannot tell us whether the cancer has spread outside the prostate.When prostate cancer spreads, the most common destination is the bones — particularly the spine, pelvis and ribs. It can also reach organs such as the lungs or liver. Once it has reached distant parts of the body, it is generally not curable, but treatment can put a brake on it for years.Prostate cancer can also be hormone-sensitive or hormone-resistant. Because it typically relies on testosterone to grow, lowering the hormone or blocking its effects can help control the cancer. Hormone-sensitive means it still responds to these treatments.Over time, most advanced or metastatic prostate cancers find ways to grow despite low testosterone levels, which mean they are now hormone-resistant. Lowering testosterone alone is no longer enough to control the cancer, so doctors have to turn to additional therapies.Knowing if the cancer has spreadThe most sensitive imaging test available today is a PSMA PET scan. It uses a radioactive tracer that seeks out a protein found on the surface of prostate cancer cells. Areas containing cancer may appear as bright spots, helping identify where the cancer has spread. The American Urological Association supports using this imaging test to determine whether high-risk prostate cancer has spread and to help establish its stage.A traditional bone scan, used for decades, highlights areas where bone is reacting to injury or disease. It remains an alternative imaging option, but PSMA PET is increasingly replacing its use.What areas light up and where matter when deciding on treatments. A single spot in the spine and cancer that has spread to the liver are both called stage 4, but they are not the same disease and may not be treated the same way.Doctors also consider how much cancer has spread. We label it as “low-volume” disease when the cancer has reached a limited number of areas. High volume is when the spread is more widespread or has reached other organs such as the liver or lungs.Both require treatment that works throughout the body. Treatment for metastatic disease generally includes therapy that works throughout the body. For men with low-volume disease, adding radiation to the prostate may also help them live longer.Biden has completed a course of radiation, but his team has not disclosed what area was treated or enough detail to determine whether his cancer would be considered low- or high-volume.Treatment has become more preciseBeyond starting more treatments earlier, doctors can increasingly tailor therapy to the biology of an individual man’s cancer. We can now test both the tumor and a patient’s own DNA for mutations that help guide treatment.Roughly 1 in 10 men with metastatic prostate cancer carries an inherited mutation affecting the body’s ability to repair DNA. The best known are BRCA1 and BRCA2, the same genes linked to some breast and ovarian cancers.Certain mutations found in the tumor or inherited DNA may make targeted drugs called PARP inhibitors an option. If a mutation is inherited, it also gives family members information they can act on through genetic counseling, testing and earlier screening.Another advance is radioligand therapy. If a scan shows that cancer cells carry a protein called PSMA, doctors can attach radiation to a molecule that seeks out that protein. Delivered through an IV, it targets cancer cells throughout the body. This approach was expanded last year to more men whose cancer had become hormone resistant.Living longer can come with costsEvery treatment can cause side effects. With hormone therapy, one of the first is often hot flashes, similar to what women experience during menopause. These are not dangerous, but they can affect a man’s quality of life.Fatigue is also common. Testosterone helps maintain muscle, so lowering it can reduce strength and energy. Regular walking and resistance training can help preserve muscle and reduce fatigue.The side effect almost no one talks about is loss of sex drive or low libido. At diagnosis, most men are thinking about staying alive, not their libido. But months later, it often matters. It is worth discussing with your care team and your partner rather than assuming it is simply the price of treatment.The side effect I worry about most is weaker bones. Low testosterone reduces bone density, while cancer deposits can weaken the bone’s structure. Follow-up care should include exercise, a bone-density scan, and ensuring adequate levels of calcium and vitamin D. For men with hormone-resistant cancer that has spread to bone, bone-protecting drugs can reduce the risk of fractures and other complications.New or worsening back pain, especially with leg weakness, numbness or trouble controlling the bladder or bowels? These could mean the cancer is pressing on the spinal cord. It is a true medical emergency that requires immediate attention.Cancer care requires a team approachIdeally, several doctors work together to coordinate a patient’s care. The urologist is often the starting point. A medical oncologist manages treatments that work throughout the body, while a radiation oncologist targets specific areas, whether that is the prostate itself or a painful bone lesion. The primary care doctor helps protect the patient’s heart and bones and looks after the person’s overall health.A man’s age, other medical conditions, ability to tolerate side effects and goals for treatment all shape treatment plans. Two men with nearly identical test results may be offered — or choose — different paths based on their health and priorities.Good communication among doctors is essential, but gaps can happen. Being your own advocate means knowing who is on your care team, asking questions and understanding your options.I also recommend bringing someone you trust to important visits for support and to take notes and help you remember what was discussed.More treatments, better testing offer hopeFor men worried about prostate cancer, talk with your health care provider about the benefits and risks of PSA testing. Black men and those with a strong family history should begin that conversation in their 40s. New urinary symptoms are often not cancer, but they still deserve attention, as does blood in the urine or semen, unexplained weight loss and/or persistent back or bone pain.For men living with advanced prostate cancer, there is reason for hope. There are more treatments and better testing than there were a decade ago, and good care pays attention to how a man feels, not just to what his scans show.The-CNN-Wire™ & © 2026 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.
Read Next Story